• Latest Posts

Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B

Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS

Spanish Neurology Biotech Launches with €7.6M Series A

Phase III Failure Sinks Drug for Rare Neurological Disorder

AskBio Takes Over French Gene Therapy Company to Treat Alzheimer’s and Huntington’s

Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia

ADVERTISEMENT

Two European Alzheimer’s Disease Treatments Show Promise in Phase II

Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M

Phase III Fail for MedDay’s Multiple Sclerosis Treatment

Scientists Connect Brain Cells to Machines Over the Internet

EU Project Set up to Fight Alzheimer’s Disease with Lasers

ADVERTISEMENT